Original Literature | Model OverView |
---|---|
Publication
Title
Acetylation of MKP-1 and the control of inflammation.
Affiliation
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN38105, USA. hongbo.chi@stjude.org
Abstract
Innate immune responses mediated by Toll-like receptors (TLRs), a class ofpattern-recognition receptors, play a critical role in the defense againstmicrobial pathogens. However, excessive TLR-mediated responses result in sepsis,autoimmunity, and chronic inflammation. To prevent deleterious activation ofTLRs, cells have evolved multiple mechanisms that inhibit innate immunereactions. Stimulation of TLRs induces the expression of the gene encoding themitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), anuclear-localized dual-specificity phosphatase that preferentiallydephosphorylates p38 MAPK and c-Jun N-terminal kinase (JNK), resulting in theattenuation of TLR-triggered production of proinflammatory cytokines. MKP-1 isposttranslationally modified by multiple mechanisms, including phosphorylation.A study now demonstrates that MKP-1 is also acetylated on a key lysine residuefollowing stimulation of TLRs. Acetylation of MKP-1 promotes the interaction ofMKP-1 with its substrate p38 MAPK, which results in dephosphorylation of p38MAPK and the inhibition of innate immunity.
PMID
18922786
|
Entity
JNK
--
MO000000023
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m30
10
infinite
0
TRANSPATH | MO000000023 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
PKCepsilon
--
MO000016645
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1629
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016645 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
MKP-1
--
MO000016814
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1752
10
infinite
0
InterPro | IPR000340 |
TRANSPATH | MO000016814 |
--
glucocorticoids
--
MO000021732
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6069
10
infinite
0
TRANSPATH | MO000021732 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
differentiation genes
--
e11
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m11
0
infinite
0
--
apoptosis
--
e12
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m12
0
infinite
0
--
proinflammatory cytokines
--
e13
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m13
0
infinite
0
--
MAP3K
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
MAP2K{p}
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
MAP2K
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
MAPK
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
MAPK{p}
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
AP-1{p}
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TLR
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
MKP-1
--
e21
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m21
0
infinite
0
--
TLR:MyD88
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
TLR:TRIF
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
PKCepsilon{active}
--
e25
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m26
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016645 |
--
JNK{active}
--
e28
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000023 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
SCF ubiquitin liagse
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
MKP-1{p}:SCF ubiquitin liagse
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
degradants
--
e32
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
ROS
--
e33
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
NOS2
--
e34
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
MKP-1:p300
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
MKP-1{Ac}:p38{p}
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
MKP-1{Ac}:p38
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m46
0
infinite
0
--
HDAC inhibitors
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
cell growth arrest genes
--
e6
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
m5*0.1
nodelay
--
0
PMID: 18922786,11902574 HDAC inhibitors induce the expression of a subset of genes involved in cell growth arrest, differentiation, and apoptosis, which accounts for the antitumor effects of these compounds
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m20*m1572*0.1
nodelay
--
0
PMID: 18922786,16497588 The signals involved in TLR-induced expression of MKP-1 are beginning to be defined. Stimulation of TLRs activates two distinct pathways that are mediated by the adaptor proteins myeloid differentiation marker 88 (MyD88) and TRIF [Toll-IL-1 receptor (TIR) domain-containing adapter-inducing interferon-beta (IFN-beta)], respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m20*m18998*0.1
nodelay
--
0
PMID: 18922786,16497588 The signals involved in TLR-induced expression of MKP-1 are beginning to be defined. Stimulation of TLRs activates two distinct pathways that are mediated by the adaptor proteins myeloid differentiation marker 88 (MyD88) and TRIF [Toll-IL-1 receptor (TIR) domain-containing adapter-inducing interferon-beta (IFN-beta)], respectively
p8
p12
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c62 : 1
stoichiometry:c29 : 1
m23*0.1
nodelay
--
0
PMID: 18922786,16461893,16380513,12444149,15590669,16978838 In macrophages responding to TLR stimulation, there is a strong and rapid induction of MKP-1 mRNA and increase in MKP-1 protein abundance, peaking at 1 hour after stimulation PMID: 18922786,16461893 TLR-induced expression of MKP-1 is reduced in mice lacking either MyD88 or TRIF compared to that in wildtype mice, suggesting that MKP-1 is induced through both MyD88- and TRIF-dependent pathways in response to activation of TLRs PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c30 : 1
stoichiometry:c32 : 1
m24*m22*0.1
nodelay
--
0
PMID: 18922786,16709817,10604989 In addition, a signaling pathway consisting of the MAP3K Raf-1 and protein kinase C epsilon (PKCepsilon) is required for TLR-induced expression of MKP-1 in macrophages
p13
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m25*m1629*0.1
nodelay
--
0
PMID: 18922786,16709817,10604989 In addition, a signaling pathway consisting of the MAP3K Raf-1 and protein kinase C epsilon (PKCepsilon) is required for TLR-induced expression of MKP-1 in macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c66 : 1
stoichiometry:c37 : 1
m26*0.1
nodelay
--
0
PMID: 18922786,16709817,10604989 In addition, a signaling pathway consisting of the MAP3K Raf-1 and protein kinase C epsilon (PKCepsilon) is required for TLR-induced expression of MKP-1 in macrophages PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-¦Ã) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c96 : 1
stoichiometry:c40 : 1
m22*m27*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1 PMID: 18922786 They found that HDAC inhibitors reduced the activation of p38 MAPK and ERK, but not JNK or the NF-KappaB pathway.
p17
p17
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c65 : 1
stoichiometry:c42 : 1
m28*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1 PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p17
p18
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c64 : 1
stoichiometry:c47 : 1
m31*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1 PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p16
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c97 : 1
stoichiometry:c45 : 1
m22*m29*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1 PMID: 18922786 They found that HDAC inhibitors reduced the activation of p38 MAPK and ERK, but not JNK or the NF-KappaB pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
m5*0.1
nodelay
--
0
PMID: 18922786,11902574 HDAC inhibitors induce the expression of a subset of genes involved in cell growth arrest, differentiation, and apoptosis, which accounts for the antitumor effects of these compounds
p16
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m22*m30*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1
p17
p21
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c63 : 1
stoichiometry:c52 : 1
m32*0.1
nodelay
--
0
PMID: 18922786,12444149,16978838,17337450 Furthermore, ERK, JNK, and p38 MAPK have all been suggested to facilitate TLR-induced expression of MKP-1 PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p22
p22
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c67 : 1
stoichiometry:c54 : 1
m6069*0.1
nodelay
--
0
PMID: 18922786 MKP-1 is also induced by multiple immunosuppressive agents, including glucocorticoids and anti-inflammatory cytokines, and this induction partially mediates the inhibitory effects of these agents on MAPK activation and inflammation PMID: 18922786 Figure 1A PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p23
p23
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c59 : 1
stoichiometry:c56 : 1
m1746*0.1
nodelay
--
0
PMID: 18922786,16184516,11842088 Induction of MKP-1 by transforming growth factor beta (TGF-beta) and IL-10 also contributes to the suppressive effects of these potent anti-inflammatory cytokines on the expression of genes encoding proinflammatory mediators. PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p23
p24
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c60 : 1
stoichiometry:c57 : 1
m2103*0.1
nodelay
--
0
PMID: 18922786,16184516,11842088 Induction of MKP-1 by transforming growth factor beta (TGF-beta) and IL-10 also contributes to the suppressive effects of these potent anti-inflammatory cytokines on the expression of genes encoding proinflammatory mediators. PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
p25
p25
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m28*m1752*0.1
nodelay
--
0
PMID: 18922786 Interestingly, MKP-1 is phosphorylated by ERK in two distinct regions, which have opposing effects on its stability PMID: 1892786,10617468 Transient activation of ERK phosphorylates MKP-1 at the two extreme C-terminal Ser359 and Ser364, which enhances MKP-1 stabilization without altering its phosphatase activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m33*m34*0.1
nodelay
--
0
PMID: 18922786,12676937,16286470 This facilitates the interaction of MKP-1 with the Skp-cullin-F-box (SCFSkp2) ubiquitin ligase, which targets MKP-1 for proteasomal degradation
p27
p27
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c77 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m35*0.1
nodelay
--
0
PMID: 18922786,12676937,16286470 This facilitates the interaction of MKP-1 with the Skp-cullin-F-box (SCFSkp2) ubiquitin ligase, which targets MKP-1 for proteasomal degradation PMID: 18922786 For example, glucocorticoids increase the expression of MKP-1 as well as attenuating proteasomal degradation of MKP-1.
p28
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m230*m37*m30*0.1
nodelay
--
0
PMID: 18922786 In the presence of the transcription factor nuclear factor-KappaB (NF-KappaB), TNF-alpha induces a rapid and transient activation of JNK.
p29
p29
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m230*m38*m30*0.1
nodelay
--
0
PMID: 18922786 Reactive oxygen species (ROS) mediate sustained JNK activation in NF- KappaB?deficient cells by inactivating MKP-1 and several other MKP molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*0.1
nodelay
--
0
PMID: 18922786,11902574 HDAC inhibitors induce the expression of a subset of genes involved in cell growth arrest, differentiation, and apoptosis, which accounts for the antitumor effects of these compounds
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m38*m1752*0.1
nodelay
--
0
PMID: 18922786 Reactive oxygen species (ROS) mediate sustained JNK activation in NF- KappaB?deficient cells by inactivating MKP-1 and several other MKP molecules. PMID: 18922786 This is achieved by ROS-induced oxidation of the catalytic Cys residue in the MKP molecules, resulting in the loss of phosphatase activity.
p31
p31
cso30:i:CE_Apoptosis_InhibitionOfCellSurvival_
cso30:i:CC_Extracellular
--
--
PMID: 18922786,15766528 Consequently, JNK activation becomes unconstrained, eventually leading to cellular apoptosis (
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
1.0*0.1
nodelay
--
0
PMID: 18922786 HDAC inhibitors down-regulated a subset of inflammationassociated genes, including nitric oxide synthase 2 (NOS2), TNFalpha, and IL-6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
1.0*0.1
nodelay
--
0
PMID: 18922786 HDAC inhibitors down-regulated a subset of inflammationassociated genes, including nitric oxide synthase 2 (NOS2), TNFalpha, and IL-6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
1.0*0.1
nodelay
--
0
PMID: 18922786 HDAC inhibitors down-regulated a subset of inflammationassociated genes, including nitric oxide synthase 2 (NOS2), TNFalpha, and IL-6.
p35
p35
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c111 : 1
stoichiometry:c100 : 1
m40*m44*0.1
nodelay
--
0
PMID: 18922786 In particular, HDAC inhibitors decreased phosphorylation of p38 MAPK and its downstream target Elk-1 but not the upstream MAP2Ks MKK3 or MKK6, suggesting that these inhibitors act upon the MAPK pathway at the level of p38, possibly upon a kinase or phosphatase that modifies p38 MAPK.
p36
p36
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m1752*m4512*m22*0.1
nodelay
--
0
PMID: 18922786 To identify the acetylated component of the p38 MAPK pathway, Cao et al. immunoprecipitated the histone acetylase p300 and showed that it was associated with MKP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m42*0.1
nodelay
--
0
PMID: 18922786 Upon stimulation of TLRs, MKP-1 was acetylated at Lys57, and mutation of this residue abrogated the acetylation of MKP-1 by p300 in vitro and in TLR-stimulated cells, suggesting that Lys57 is the crucial residue required for the acetylation of MKP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c109 : 1
stoichiometry:c113 : 1
m44*m43*0.1
nodelay
--
0
PMID: 18922786 Through a number of biochemical approaches, the authors demonstrated that acetylation of MKP-1 potentiated the interaction between MKP-1 and p38 and, consequently, increased the dephosphorylation of p38 by MKP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c101 : 1
stoichiometry:c110 : 1
m29*0.1
nodelay
--
0
PMID: 18922786 In particular, HDAC inhibitors decreased phosphorylation of p38 MAPK and its downstream target Elk-1 but not the upstream MAP2Ks MKK3 or MKK6, suggesting that these inhibitors act upon the MAPK pathway at the level of p38, possibly upon a kinase or phosphatase that modifies p38 MAPK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
1.0*0.1
nodelay
--
0
PMID: 18922786 Paradoxically, HDAC inhibitors also possess potent anti-inflammatory effects by shutting down the expression of genes encoding proinflammatory cytokines and molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m45*0.1
nodelay
--
0
PMID: 18922786 Through a number of biochemical approaches, the authors demonstrated that acetylation of MKP-1 potentiated the interaction between MKP-1 and p38 and, consequently, increased the dephosphorylation of p38 by MKP-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m14*m16*0.1
nodelay
--
0
PMID: 18922786 Activation of MAPK is mediated by a core kinase module consisting of MAPK kinase kinase (MAPKKK, also known as MAP3K), MAPK kinase (MAPKK, also known as MAP2K), and MAPK through sequential protein phosphorylations.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m15*m17*0.1
nodelay
--
0
PMID: 18922786 Activation of MAPK is mediated by a core kinase module consisting of MAPK kinase kinase (MAPKKK, also known as MAP3K), MAPK kinase (MAPKK, also known as MAP2K), and MAPK through sequential protein phosphorylations.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m18*m219*0.1
nodelay
--
0
PMID: 18922786,11274345,11861597 Activated MAPKs, in turn, phosphorylate activating protein 1 (AP-1) transcription factors and other targets to stimulate gene transcription and immune responses
p8
p8
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c61 : 1
stoichiometry:c19 : 1
m22*0.1
nodelay
--
0
PMID: 18922786,16461893,16380513,12444149,15590669,16978838 In macrophages responding to TLR stimulation, there is a strong and rapid induction of MKP-1 mRNA and increase in MKP-1 protein abundance, peaking at 1 hour after stimulation PMID: 18922786,16461893 TLR-induced expression of MKP-1 is reduced in mice lacking either MyD88 or TRIF compared to that in wildtype mice, suggesting that MKP-1 is induced through both MyD88- and TRIF-dependent pathways in response to activation of TLRs PMID: 18922786,16380513 Conversely, proinflammatory stimuli such as interferon ¦Ã (IFN-gamma) attenuate MKP-1 expression to facilitate their positive effects on MAPK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m21*0.1
nodelay
--
0
PMID: 18922786,16461893,16380513,12444149,15590669,16978838 In macrophages responding to TLR stimulation, there is a strong and rapid induction of MKP-1 mRNA and increase in MKP-1 protein abundance, peaking at 1 hour after stimulation PMID: 18922786,16461893 TLR-induced expression of MKP-1 is reduced in mice lacking either MyD88 or TRIF compared to that in wildtype mice, suggesting that MKP-1 is induced through both MyD88- and TRIF-dependent pathways in response to activation of TLRs
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--